4//SEC Filing
Yanez Michelle 4
Accession 0001493152-24-034962
CIK 0001971532other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 1:37 PM ET
Size
5.9 KB
Accession
0001493152-24-034962
Insider Transaction Report
Form 4
Yanez Michelle
Chief Financial Officer
Transactions
- Award
Incentive Stock Options (right to buy)
2024-08-27+200,000→ 200,000 totalExercise: $5.02Exp: 2034-08-27→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.
- [F2]The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50,000 stock options of such grant shall vest, respectively, on each of February 26, 2025, August 26, 2025, February 26, 2026 and August 26, 2026.
Documents
Issuer
Telomir Pharmaceuticals, Inc.
CIK 0001971532
Entity typeother
Related Parties
1- filerCIK 0001958023
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 1:37 PM ET
- Size
- 5.9 KB